{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:20:26Z","timestamp":1792052426361,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["24094"],"award-info":[{"award-number":["24094"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03333-5","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T03:47:13Z","timestamp":1763092033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation of contrast-enhancing tumor region on pre-radiotherapy MRI with overall survival in glioblastoma"],"prefix":"10.1186","volume":"30","author":[{"given":"Atefeh","family":"Mahmoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash Zare","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Iraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Barahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-2140","authenticated-orcid":false,"given":"Seied Rabi","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"1","key":"3333_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7555\/JBR.36.20220156","volume":"37","author":"J Li","year":"2022","unstructured":"Li J, Feng L, Lu Y. Glioblastoma multiforme: diagnosis, treatment, and invasion. J Biomed Res. 2022;37(1):47.","journal-title":"J Biomed Res"},{"issue":"3","key":"3333_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2159-8290.CD-20-1474","volume":"11","author":"JG Nicholson","year":"2021","unstructured":"Nicholson JG, Fine HA. Diffuse glioma heterogeneity and its therapeutic implications. Cancer Discov. 2021;11(3):575\u201390.","journal-title":"Cancer Discov"},{"issue":"4","key":"3333_CR3","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70(4):299\u2013312.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3333_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","volume":"21","author":"K Yang","year":"2022","unstructured":"Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, et al. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer. 2022;21(1):39.","journal-title":"Mol Cancer"},{"issue":"8","key":"3333_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/cancers11081148","volume":"11","author":"A Chaddad","year":"2019","unstructured":"Chaddad A, Daniel P, Sabri S, Desrosiers C, Abdulkarim B. Integration of radiomic and multi-omic analyses predicts survival of newly diagnosed IDH1 wild-type glioblastoma. Cancers. 2019;11(8):1148.","journal-title":"Cancers"},{"issue":"10","key":"3333_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1177\/0284185118756951","volume":"59","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhang X, Feng N, Yin L, He Y, Xu X, et al. The effect of glioblastoma heterogeneity on survival stratification: a multimodal MR imaging texture analysis. Acta Radiol. 2018;59(10):1239\u201346.","journal-title":"Acta Radiol"},{"issue":"6","key":"3333_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.irbm.2015.08.001","volume":"36","author":"T Upadhaya","year":"2015","unstructured":"Upadhaya T, Morvan Y, Stindel E, Le Reste P-J, Hatt M. A framework for multimodal imaging-based prognostic model building: preliminary study on multimodal MRI in glioblastoma multiforme. Irbm. 2015;36(6):345\u201350.","journal-title":"Irbm"},{"key":"3333_CR8","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s00330-020-07387-3","volume":"31","author":"TC Booth","year":"2021","unstructured":"Booth TC, Luis A, Brazil L, Thompson G, Daniel RA, Shuaib H, et al. Glioblastoma post-operative imaging in neuro-oncology: current UK practice (GIN CUP study). Eur Radiol. 2021;31:2933\u201343.","journal-title":"Eur Radiol"},{"key":"3333_CR9","doi-asserted-by":"publisher","first-page":"105972","DOI":"10.1016\/j.clineuro.2020.105972","volume":"196","author":"A De Barros","year":"2020","unstructured":"De Barros A, Attal J, Roques M, Nicolau J, Sol J-C, Charni S, et al. Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: a retrospective observational study. Clin Neurol Neurosurg. 2020;196:105972.","journal-title":"Clin Neurol Neurosurg"},{"issue":"18","key":"3333_CR10","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.3390\/cancers15184636","volume":"15","author":"W Farzana","year":"2023","unstructured":"Farzana W, Basree MM, Diawara N, Shboul ZA, Dubey S, Lockhart MM, et al. Prediction of rapid early progression and survival risk with pre-radiation MRI in WHO grade 4 glioma patients. Cancers. 2023;15(18):4636.","journal-title":"Cancers"},{"issue":"1","key":"3333_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41598-020-79829-3","volume":"11","author":"A Garcia-Ruiz","year":"2021","unstructured":"Garcia-Ruiz A, Naval-Baudin P, Ligero M, Pons-Escoda A, Bruna J, Plans G, et al. Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma. Sci Rep. 2021;11(1):695.","journal-title":"Sci Rep"},{"issue":"9","key":"3333_CR12","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/neuonc\/noy053","volume":"20","author":"BM Ellingson","year":"2018","unstructured":"Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, et al. Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro-oncol. 2018;20(9):1240\u201350.","journal-title":"Neuro-oncol"},{"issue":"5","key":"3333_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3171\/2014.7.JNS132449","volume":"121","author":"MM Grabowski","year":"2014","unstructured":"Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, et al. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg. 2014;121(5):1115\u201323.","journal-title":"J Neurosurg"},{"key":"3333_CR14","doi-asserted-by":"publisher","first-page":"S424","DOI":"10.1016\/j.annonc.2024.08.562","volume":"35","author":"KV Cano","year":"2024","unstructured":"Cano KV, Garre J, Nu\u00f1ez F, Gomez M, Baselga PM, Cerna JY, et al. 493p the usefulness of pre-radiotherapy MRI in assessing pseudo-progression in patients with glioblastoma included in first-line clinical trials. Ann Oncol. 2024;35:S424.","journal-title":"Ann Oncol"},{"issue":"5","key":"3333_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/nop\/npac044","volume":"9","author":"RD Kraus","year":"2022","unstructured":"Kraus RD, Weil CR, Frances Su F-C, Cannon DM, Burt LM, Mendez JS. Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients. Neuro-oncol Pract. 2022;9(5):380\u20139.","journal-title":"Neuro-oncol Pract"},{"issue":"12","key":"3333_CR16","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3174\/ajnr.A4917","volume":"37","author":"C Maj\u00f3s","year":"2016","unstructured":"Maj\u00f3s C, Cos M, Casta\u00f1er S, Pons A, Gil M, Fern\u00e1ndez-Coello A, et al. Preradiotherapy MR imaging: a prospective pilot study of the usefulness of performing an MR examination shortly before radiation therapy in patients with glioblastoma. AJNR Am J Neuroradiol. 2016;37(12):2224\u201330.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3333_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejca.2023.04.021","volume":"188","author":"A Alafandi","year":"2023","unstructured":"Alafandi A, van Garderen K, Klein S, van der Voort S, Rizopoulos D, Nabors L, et al. Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status. Eur J Cancer. 2023;188:122\u201330.","journal-title":"Eur J Cancer"},{"key":"3333_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11060-008-9685-3","volume":"91","author":"S Saraswathy","year":"2009","unstructured":"Saraswathy S, Crawford FW, Lamborn KR, Pirzkall A, Chang S, Cha S, et al. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol. 2009;91:69\u201381.","journal-title":"J Neurooncol"},{"issue":"2","key":"3333_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563\u201377.","journal-title":"Radiology"},{"issue":"12","key":"3333_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RT, Deist TM, Peerlings J, De Jong EE, Van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"3333_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/diagnostics14020181","volume":"14","author":"E Yazdani","year":"2024","unstructured":"Yazdani E, Geramifar P, Karamzade-Ziarati N, Sadeghi M, Amini P, Rahmim A. Radiomics and artificial intelligence in radiotheranostics: a review of applications for radioligands targeting somatostatin receptors and prostate-specific membrane antigens. Diagnostics. 2024;14(2):181.","journal-title":"Diagnostics"},{"issue":"3","key":"3333_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ijrobp.2025.05.014","volume":"123","author":"E Yazdani","year":"2025","unstructured":"Yazdani E, Sadeghi M, Karamzade-Ziarati N, Jabari P, Amini P, Vosoughi H, et al. Machine learning-based dose prediction in [177Lu]Lu-PSMA-617 therapy by integrating biomarkers and radiomic features from [68Ga]Ga-PSMA-11 PET\/CT. Int J Radiat Oncol Biol Phys. 2025;123(3):891\u2013908.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"3333_CR23","doi-asserted-by":"publisher","first-page":"e70030","DOI":"10.1002\/mp.70030","volume":"52","author":"E Yazdani","year":"2025","unstructured":"Yazdani E, Neizehbaz A, Karamzade-Ziarati N, Emami F, Vosoughi H, Asadi M, et al. Transforming [177Lu]Lu-PSMA-617 treatment planning: machine learning-based radiodosiomics and swin UNETR using pretherapy PSMA PET\/CT. Med Phys. 2025;52(10):e70030.","journal-title":"Med Phys"},{"key":"3333_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","volume":"26","author":"K Clark","year":"2013","unstructured":"Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, et al. The cancer imaging archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26:1045\u201357.","journal-title":"J Digit Imaging"},{"issue":"1","key":"3333_CR25","doi-asserted-by":"publisher","first-page":"14331","DOI":"10.1038\/s41598-017-14753-7","volume":"7","author":"Q Li","year":"2017","unstructured":"Li Q, Bai H, Chen Y, Sun Q, Liu L, Zhou S, et al. A fully-automatic multiparametric radiomics model: towards reproducible and prognostic imaging signature for prediction of overall survival in glioblastoma multiforme. Sci Rep. 2017;7(1):14331.","journal-title":"Sci Rep"},{"key":"3333_CR26","doi-asserted-by":"publisher","first-page":"661123","DOI":"10.3389\/fonc.2021.661123","volume":"11","author":"M Soltani","year":"2021","unstructured":"Soltani M, Bonakdar A, Shakourifar N, Babaei R, Raahemifar K. Efficacy of location-based features for survival prediction of patients with glioblastoma depending on resection status. Front Oncol. 2021;11:661123.","journal-title":"Front Oncol"},{"issue":"20","key":"3333_CR27","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.3390\/cancers13205047","volume":"13","author":"S Cepeda","year":"2021","unstructured":"Cepeda S, P\u00e9rez-Nu\u00f1ez A, Garc\u00eda-Garc\u00eda S, Garc\u00eda-P\u00e9rez D, Arrese I, Jim\u00e9nez-Rold\u00e1n L, et al. Predicting short-term survival after gross total or near total resection in glioblastomas by machine learning-based radiomic analysis of preoperative MRI. Cancers. 2021;13(20):5047.","journal-title":"Cancers"},{"issue":"11","key":"3333_CR28","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/diagnostics11112043","volume":"11","author":"S Ammari","year":"2021","unstructured":"Ammari S, de Chou RS, Balleyguier C, Chouzenoux E, Touat M, Quillent A, et al. A predictive clinical-radiomics nomogram for survival prediction of glioblastoma using MRI. Diagnostics. 2021;11(11):2043.","journal-title":"Diagnostics"},{"key":"3333_CR29","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s11517-018-1858-4","volume":"56","author":"A Chaddad","year":"2018","unstructured":"Chaddad A, Sabri S, Niazi T, Abdulkarim B. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients. Med Biol Eng Comput. 2018;56:2287\u2013300.","journal-title":"Med Biol Eng Comput"},{"key":"3333_CR30","doi-asserted-by":"publisher","first-page":"778627","DOI":"10.3389\/fonc.2021.778627","volume":"11","author":"B Wang","year":"2021","unstructured":"Wang B, Zhang S, Wu X, Li Y, Yan Y, Liu L, et al. Multiple survival outcome prediction of glioblastoma patients based on multiparametric MRI. Front Oncol. 2021;11:778627.","journal-title":"Front Oncol"},{"key":"3333_CR31","doi-asserted-by":"publisher","first-page":"758622","DOI":"10.3389\/fonc.2022.758622","volume":"12","author":"X Jia","year":"2022","unstructured":"Jia X, Zhai Y, Song D, Wang Y, Wei S, Yang F, et al. A multiparametric MRI-based radiomics nomogram for preoperative prediction of survival stratification in glioblastoma patients with standard treatment. Front Oncol. 2022;12:758622.","journal-title":"Front Oncol"},{"issue":"4","key":"3333_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.suronc.2018.09.002","volume":"27","author":"P Sanghani","year":"2018","unstructured":"Sanghani P, Ang BT, King NKK, Ren H. Overall survival prediction in glioblastoma multiforme patients from volumetric, shape and texture features using machine learning. Surg Oncol. 2018;27(4):709\u201314.","journal-title":"Surg Oncol"},{"issue":"2","key":"3333_CR33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1109\/JBHI.2018.2825027","volume":"23","author":"A Chaddad","year":"2018","unstructured":"Chaddad A, Daniel P, Desrosiers C, Toews M, Abdulkarim B. Novel radiomic features based on joint intensity matrices for predicting glioblastoma patient survival time. IEEE J Biomed Health Inform. 2018;23(2):795\u2013804.","journal-title":"IEEE J Biomed Health Inform"},{"key":"3333_CR34","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s11517-019-01986-z","volume":"57","author":"P Sanghani","year":"2019","unstructured":"Sanghani P, Ang BT, King NKK, Ren H. Regression based overall survival prediction of glioblastoma multiforme patients using a single discovery cohort of multi-institutional multi-channel MR images. Med Biol Eng Comput. 2019;57:1683\u201391.","journal-title":"Med Biol Eng Comput"},{"issue":"1","key":"3333_CR35","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1038\/s41598-024-53006-2","volume":"14","author":"S Babaei Rikan","year":"2024","unstructured":"Babaei Rikan S, Sorayaie Azar A, Naemi A, Bagherzadeh Mohasefi J, Pirnejad H, Wiil UK. Survival prediction of glioblastoma patients using modern deep learning and machine learning techniques. Sci Rep. 2024;14(1):2371.","journal-title":"Sci Rep"},{"issue":"2","key":"3333_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jimaging7020017","volume":"7","author":"M Baine","year":"2021","unstructured":"Baine M, Burr J, Du Q, Zhang C, Liang X, Krajewski L, et al. The potential use of radiomics with pre-radiation therapy MR imaging in predicting risk of pseudoprogression in glioblastoma patients. J Imaging. 2021;7(2):17.","journal-title":"J Imaging"},{"key":"3333_CR37","doi-asserted-by":"publisher","first-page":"109964","DOI":"10.1016\/j.radonc.2023.109964","volume":"190","author":"MM i Garau","year":"2024","unstructured":"i Garau MM, Escoda AP, Exp\u00f3sito NG, Calduch AL. On the advice to perform a new MRI within 2 weeks prior to radiotherapy start for glioblastoma according ESTRO-EANO guideline. Radiother Oncol. 2024;190:109964.","journal-title":"Radiother Oncol"},{"issue":"3","key":"3333_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1148\/radiol.2021202553","volume":"298","author":"MR Tomaszewski","year":"2021","unstructured":"Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology. 2021;298(3):505\u201316.","journal-title":"Radiology"},{"issue":"13","key":"3333_CR39","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.3390\/cancers15133523","volume":"15","author":"T Mukherjee","year":"2023","unstructured":"Mukherjee T, Pournik O, Lim Choi Keung SN, Arvanitis TN. Clinical decision support systems for brain tumour diagnosis and prognosis: a systematic review. Cancers. 2023;15(13):3523.","journal-title":"Cancers"},{"key":"3333_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fonc.2019.00374","volume":"9","author":"A Chaddad","year":"2019","unstructured":"Chaddad A, Kucharczyk MJ, Daniel P, Sabri S, Jean-Claude BJ, Niazi T, et al. Radiomics in glioblastoma: current status and challenges facing clinical implementation. Front Oncol. 2019;9:374.","journal-title":"Front Oncol"},{"issue":"2","key":"3333_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41571-022-00707-0","volume":"20","author":"EP Huang","year":"2023","unstructured":"Huang EP, O\u2019Connor JP, McShane LM, Giger ML, Lambin P, Kinahan PE, et al. Criteria for the translation of radiomics into clinically useful tests. Nat Rev Clin Oncol. 2023;20(2):69\u201382.","journal-title":"Nat Rev Clin Oncol"},{"issue":"18","key":"3333_CR42","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3390\/diagnostics14182100","volume":"14","author":"M Mascarenhas","year":"2024","unstructured":"Mascarenhas M, Martins M, Ribeiro T, Afonso J, Cardoso P, Mendes F, et al. Software as a medical device (SaMD) in digestive healthcare: regulatory challenges and ethical implications. Diagnostics. 2024;14(18):2100.","journal-title":"Diagnostics"},{"issue":"2","key":"3333_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/jpm12020275","volume":"12","author":"A Naeem","year":"2022","unstructured":"Naeem A, Anees T, Naqvi RA, Loh W-K. A comprehensive analysis of recent deep and federated-learning-based methodologies for brain tumor diagnosis. J Pers Med. 2022;12(2):275.","journal-title":"J Pers Med"},{"issue":"5","key":"3333_CR44","doi-asserted-by":"publisher","first-page":"102023","DOI":"10.1016\/j.jmir.2025.102023","volume":"56","author":"E Yazdani","year":"2025","unstructured":"Yazdani E, Neizehbaz A, Karamzade-Ziarati N, Kheradpisheh SR. Explainable artificial intelligence for pneumonia classification: clinical insights into deformable prototypical part network in pediatric chest x-ray images. J Med Imaging Radiat Sci. 2025;56(5):102023.","journal-title":"J Med Imaging Radiat Sci"},{"key":"3333_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07314-y","author":"I Buvat","year":"2025","unstructured":"Buvat I, Dutta J, Jha AK, Siegel E, Yousefirizi F, Rahmim A, et al. Should end-to-end deep learning replace handcrafted radiomics? Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07314-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"3333_CR46","doi-asserted-by":"publisher","first-page":"10353","DOI":"10.1038\/s41598-017-10649-8","volume":"7","author":"J Lao","year":"2017","unstructured":"Lao J, Chen Y, Li Z-C, Li Q, Zhang J, Liu J, et al. A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme. Sci Rep. 2017;7(1):10353.","journal-title":"Sci Rep"},{"issue":"1","key":"3333_CR47","first-page":"5518717","volume":"2021","author":"Z Liu","year":"2021","unstructured":"Liu Z, Jiang Z, Meng L, Yang J, Liu Y, Zhang Y, et al. Handcrafted and deep learning-based radiomic models can distinguish GBM from brain metastasis. J Oncol. 2021;2021(1):5518717.","journal-title":"J Oncol"},{"issue":"4","key":"3333_CR48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1109\/MSP.2019.2900993","volume":"36","author":"P Afshar","year":"2019","unstructured":"Afshar P, Mohammadi A, Plataniotis KN, Oikonomou A, Benali H. From handcrafted to deep-learning-based cancer radiomics: challenges and opportunities. IEEE Signal Process Mag. 2019;36(4):132\u201360.","journal-title":"IEEE Signal Process Mag"},{"issue":"12","key":"3333_CR49","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.3390\/cancers15123158","volume":"15","author":"A Barzegar Behrooz","year":"2023","unstructured":"Barzegar Behrooz A, Latifi-Navid H, da Silva Rosa SC, Swiat M, Wiechec E, Vitorino C, et al. Integrating multi-omics analysis for enhanced diagnosis and treatment of glioblastoma: a comprehensive data-driven approach. Cancers. 2023;15(12):3158.","journal-title":"Cancers"},{"issue":"100","key":"3333_CR50","first-page":"1","volume":"24","author":"D Zeng","year":"2023","unstructured":"Zeng D, Liang S, Hu X, Wang H, Xu Z. Fedlab: a flexible federated learning framework. J Mach Learn Res. 2023;24(100):1\u20137.","journal-title":"J Mach Learn Res"},{"issue":"6","key":"3333_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/MIS.2021.3082561","volume":"36","author":"K Cheng","year":"2021","unstructured":"Cheng K, Fan T, Jin Y, Liu Y, Chen T, Papadopoulos D, et al. Secureboost: a lossless federated learning framework. IEEE Intell Syst. 2021;36(6):87\u201398.","journal-title":"IEEE Intell Syst"},{"issue":"Suppl 6","key":"3333_CR52","doi-asserted-by":"publisher","first-page":"vi176","DOI":"10.1093\/neuonc\/noz175.737","volume":"21","author":"M Sheller","year":"2019","unstructured":"Sheller M, Edwards B, Reina GA, Martin J, Bakas S. NIMG-68. Federated learning in neuro-oncology for multi-institutional collaborations without sharing patient data. Neuro-oncol. 2019;21(Suppl 6):vi176.","journal-title":"Neuro-oncol"},{"key":"3333_CR53","doi-asserted-by":"crossref","unstructured":"Chang X, Li W, Zomaya AY, editors. Fed-GBM: A cost-effective federated gradient boosting tree for non-intrusive load monitoring. Proceedings of the Thirteenth ACM International Conference on Future Energy Systems; 2022.","DOI":"10.1145\/3538637.3538840"},{"issue":"1","key":"3333_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/trf.18077","volume":"65","author":"N Li","year":"2025","unstructured":"Li N, Lewin A, Ning S, Waito M, Zeller MP, Tinmouth A, et al. Privacy-preserving federated data access and federated learning: improved data sharing and AI model development in transfusion medicine. Transfusion. 2025;65(1):22\u20138.","journal-title":"Transfusion"},{"key":"3333_CR55","doi-asserted-by":"publisher","first-page":"101249","DOI":"10.1016\/j.imu.2023.101249","volume":"39","author":"B Huber","year":"2023","unstructured":"Huber B, Pellumbi N, Davoodi-Bojd E, Soltanian-Zadeh H. Inter-and intra-operator variations in manual segmentation of hippocampus from MRI. Inf Med Unlocked. 2023;39:101249.","journal-title":"Inf Med Unlocked"},{"issue":"5","key":"3333_CR56","doi-asserted-by":"publisher","first-page":"101470","DOI":"10.1016\/j.adro.2024.101470","volume":"9","author":"T Matoska","year":"2024","unstructured":"Matoska T, Patel M, Liu H, Beriwal S. Review of deep learning based autosegmentation for clinical target volume: current status and future directions. Adv Radiat Oncol. 2024;9(5):101470.","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"3333_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40644-024-00675-x","volume":"24","author":"E Yazdani","year":"2024","unstructured":"Yazdani E, Karamzadeh-Ziarati N, Cheshmi SS, Sadeghi M, Geramifar P, Vosoughi H, et al. Automated segmentation of lesions and organs at risk on [68Ga] Ga-PSMA-11 PET\/CT images using self-supervised learning with Swin UNETR. Cancer Imaging. 2024;24(1):30.","journal-title":"Cancer Imaging"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03333-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03333-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03333-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:07:49Z","timestamp":1763100469000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03333-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3333"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03333-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since the dataset utilized in this study is publicly accessible, an ethics statement is not necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1121"}}